Azpamin Tablets
PDF Leaflet Revision Date: 22 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
To reduce the risk of myocardial infarction and stroke.
Dosage (summary)
100 mg daily, preferably at the same time each day.
Onset of Action / Duration
Onset: 30 mins, Duration: Not specified.
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in the third trimester; not recommended during breastfeeding.
Key Drug Interactions
- Methotrexate (u226515 mg/week)
- Anticoagulants
- SSRIs
- Alcohol
Contraindications
- Hypersensitivity to acetylsalicylic acid
- Severe renal or hepatic impairment
- Last trimester of pregnancy
- Active gastrointestinal ulcers
Common side effects
- Gastrointestinal disturbances
- Nausea
- Dizziness
- Hypertension
Counselling Points
- Take with plenty of water and preferably before meals.
- Avoid use in children under 16 unless indicated.
- Report any signs of gastrointestinal bleeding.
Serious warnings
- Increased bleeding tendency
- Risk of gastrointestinal bleeding
- Serious skin reactions
Important Disclaimer
The Azpamin Tablets professional information leaflet below is the property of Forrester Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
